Swissmedic

Zug's Pharma and Biotech Sector: Why Roche, Novartis, and Global Life Sciences Chose Switzerland

Switzerland is the world's leading pharmaceutical nation by export value. Roche and Novartis — two of the world's five largest drug companies by revenue — are Swiss institutions. Canton Zug sits at the intersection of the Basel pharma cluster, the Zurich biotech hub, and Switzerland's IP-favourable tax framework, making it a critical node in the global life sciences industry's European infrastructure.